Stakeholder engagement in economic evaluation: Protocol for using the nominal group technique to elicit patient, healthcare provider, and health system stakeholder input in the development of an early economic evaluation model of chimeric antigen receptor T-cell therapy

INTRODUCTION: Chimeric antigen receptor T-cell (CAR-T) therapy is a class of immunotherapy. An economic evaluation conducted at an early stage of development of CAR-T therapy for treatment of adult relapsed or refractory acute lymphoblastic leukaemia could provide insight into factors contributing t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Mackenzie, Thavorn, Kednapa, Hawrysh, Terry, Graham, Ian D, Atkins, Harold, Kekre, Natasha, Coyle, Doug, Lalu, Manoj M, Fergusson, Dean A, Chan, Kelvin KW, Ollendorf, Daniel A, Presseau, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Health Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362692/
https://www.ncbi.nlm.nih.gov/pubmed/34385243
http://dx.doi.org/10.1136/bmjopen-2020-046707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362692/
https://www.ncbi.nlm.nih.gov/pubmed/34385243
http://dx.doi.org/10.1136/bmjopen-2020-046707

Ejemplares similares